Elpiscience services

Elpiscience has assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration trials.

Elpiscience’s proprietary discovery technologies enable efficient generation of innovative cancer immunotherapies.

Elpiscience leverages our deep understanding of tumor biology and mechanisms of action to translate target biology for challenging pathways, develop biomarkers and strategically select indications and patients for clinical studies.  We apply cutting-edge technologies including gene editing for target screening, single cell sequencing and advanced bioinformatics with over 1,000 tumor organoid model collections that mimic the complex interaction between the human immune system and tumor microenvironment.